Cidara Therapeutics Inc (NASDAQ:CDTX)
| 1.16 Delayed Data As of Mar 24 |  -0.27 / -18.88%Today’s Change | 0.40 Today|||52-Week Range 2.10 | +53.38% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $138.8M |
Company Description
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Contact Information
Cidara Therapeutics, Inc. 6310 Nancy Ridge Drive San Diego California 92121 |
Employees
Shareholders
| Mutual fund holders | 8.02% |
| Other institutional | 30.86% |
| Individual stakeholders | 21.48% |
Top Executives
| Jeffrey L. Stein | President, Chief Executive Officer & Director |
| Shane M. Ward | Chief Operating & Legal Officer |
| Preetam Shah | Chief Financial, Accounting & Business Officer |
| Les Tari | Chief Scientific Officer |
| Taylor Sandison | Chief Medical Officer |
